BRENDA LANE: Open Payments
NPI 1013010560 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,982 in 158 payments from 18 companies in 2025. Trend: 2023 $3,332 · 2024 $3,660 · 2025 $2,982
Food & beverage: $2,982
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $460 |
| Amgen Inc. | 12 | $249 |
| Novartis Pharmaceuticals Corporation | 12 | $242 |
| Arcutis Biotherapeutics, Inc. | 4 | $220 |
| Galderma Laboratories, L.P. | 17 | $203 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $194 |
| PFIZER INC. | 12 | $192 |
| Regeneron Healthcare Solutions, Inc. | 7 | $176 |
| UCB, Inc. | 9 | $170 |
| Janssen Biotech, Inc. | 9 | $157 |
Products named: SKYRIZI, OTEZLA, Zoryve, COSENTYX, DUPIXENT, CIBINQO, RINVOQ, Bimzelx.
Industry payments across KS — which companies pay providers there.
